Foundational characteristics of cancer include proliferation, angiogenesis, migration, evasion of apoptosis, and cellular immortality. Find key markers for these cellular processes and antibodies to detect them.
The SUMOplot™ Analysis Program predicts and scores sumoylation sites in your protein. SUMOylation is a post-translational modification involved in various cellular processes, such as nuclear-cytosolic transport, transcriptional regulation, apoptosis, protein stability, response to stress, and progression through the cell cycle.
The Autophagy Receptor Motif Plotter predicts and scores autophagy receptor binding sites in your protein. Identifying proteins connected to this pathway is critical to understanding the role of autophagy in physiological as well as pathological processes such as development, differentiation, neurodegenerative diseases, stress, infection, and cancer.
WWP1 Antibody (Center) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
| Primary Accession | Q9H0M0 |
|---|---|
| Other Accession | NP_008944.1 |
| Clone Names | 90826018 |
| Gene ID | 11059 |
|---|---|
| Other Names | NEDD4-like E3 ubiquitin-protein ligase WWP1, 632-, Atrophin-1-interacting protein 5, AIP5, TGIF-interacting ubiquitin ligase 1, Tiul1, WW domain-containing protein 1, WWP1 |
| Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
| Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
| Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
| Name | WWP1 |
|---|---|
| Function | E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates. Ubiquitinates ERBB4 isoforms JM-A CYT-1 and JM-B CYT-1, KLF2, KLF5 and TP63 and promotes their proteasomal degradation. Ubiquitinates RNF11 without targeting it for degradation. Ubiquitinates and promotes degradation of TGFBR1; the ubiquitination is enhanced by SMAD7. Ubiquitinates SMAD6 and SMAD7. Ubiquitinates and promotes degradation of SMAD2 in response to TGF-beta signaling, which requires interaction with TGIF. |
| Cellular Location | Cytoplasm. Cell membrane; Peripheral membrane protein. Nucleus |
| Tissue Location | Detected in heart, placenta, pancreas, kidney, liver, skeletal muscle, bone marrow, fetal brain, and at much lower levels in adult brain and lung. Isoform 1 and isoform 5 predominate in all tissues tested, except in testis and bone marrow, where isoform 5 is expressed at much higher levels than isoform 1 |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
WW domain-containing proteins are found in all eukaryotesand play an important role in the regulation of a wide variety ofcellular functions such as protein degradation, transcription, andRNA splicing. This gene encodes a protein which contains 4 tandemWW domains and a HECT (homologous to the E6-associated proteincarboxyl terminus) domain. The encoded protein belongs to a familyof NEDD4-like proteins, which are E3 ubiquitin-ligase molecules andregulate key trafficking decisions, including targeting of proteinsto proteosomes or lysosomes. Alternative splicing of this genegenerates at least 6 transcript variants; however, the full lengthnature of these transcripts has not been defined. [provided byRefSeq].
References
Edwards, T.L., et al. Biochem. J. 423(1):31-39(2009)Li, Y., et al. Oncogene 28(33):2948-2958(2009)Xin, X., et al. Genome Res. 19(7):1262-1269(2009)Chen, C., et al. Int. J. Cancer 124(12):2829-2836(2009)Eastman, S.W., et al. J. Cell Biol. 184(6):881-894(2009)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.
Ordering Information
Other Products
Shipping Information
